| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.600 | None | 1.000 | 34 | 1 | 1990 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
phenotype | 0.600 | None | 0.964 | 28 | 1 | 1997 | 2020 | ||||||||
|
TNF receptor superfamily member 1A | 0.409 | 0.923 | 0.99 |
|
phenotype | 0.520 | None | 1.000 | 4 | 0 | 2001 | 2009 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
phenotype | 0.380 | None | 1.000 | 9 | 0 | 2002 | 2019 | ||||||||
|
growth differentiation factor 15 | 0.429 | 0.808 | 3.0E-07 |
|
phenotype | 0.380 | None | 1.000 | 9 | 0 | 2009 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
phenotype | 0.360 | None | 0.833 | 6 | 0 | 2007 | 2019 | ||||||||
|
ZFP36 ring finger protein | 0.523 | 0.692 | 0.75 |
|
phenotype | 0.340 | None | 1.000 | 6 | 0 | 2001 | 2013 | ||||||||
|
parathyroid hormone like hormone | 0.453 | 0.846 | 0.81 |
|
phenotype | 0.310 | None | 1.000 | 2 | 0 | 2007 | 2019 | ||||||||
|
ghrelin and obestatin prepropeptide | 0.517 | 0.769 | 1.4E-11 |
|
phenotype | 0.310 | None | 1.000 | 2 | 0 | 2003 | 2007 | ||||||||
|
myostatin | 0.528 | 0.731 | 0.51 |
|
phenotype | 0.300 | None | 1.000 | 12 | 0 | 2008 | 2019 | ||||||||
|
cadherin 6 | 0.691 | 0.385 | 0.92 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
CD27 molecule | 0.517 | 0.692 | 1.0E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
phenotype | 0.230 | None | 1.000 | 4 | 0 | 2004 | 2018 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
phenotype | 0.210 | None | 1.000 | 2 | 0 | 2004 | 2007 | ||||||||
|
BRCA1 associated RING domain 1 | 0.597 | 0.538 | 1.4E-24 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
solute carrier family 25 member 4 | 0.568 | 0.692 | 0.45 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 | 0.682 | 0.423 | 1.5E-14 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
DEAD-box helicase 42 | 0.861 | 0.115 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 | 0.529 | 0.808 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
lipin 1 | 0.601 | 0.692 | 6.5E-13 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
phenotype | 0.130 | None | 1.000 | 3 | 1 | 2014 | 2020 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
phenotype | 0.110 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
sodium leak channel, non-selective | 0.587 | 0.615 | 8.5E-14 |
|
phenotype | 0.110 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
DNA polymerase gamma, catalytic subunit | 0.457 | 0.846 | 2.1E-09 |
|
phenotype | 0.110 | None | < 0.001 | 1 | 0 | 2013 | 2013 |